The applicant name appears in FDA premarket approval records as Vistakon, Division of Johnson & Johnson Vision Car, with a Jacksonville, Florida filing address at 7500 Centurion Parkway, Suite 100. The documented device is a senofilcon A hydrophilic soft contact lens, classified as a soft contact lens for extended wear, class 3, under regulation number 886.5925 and product code LPM, with the ophthalmic advisory committee recorded on the filings. The original approval, P040045, was decided on December 20, 2005, following a good manufacturing inspection dated January 28, 2005. [4][9][1]

The approved device and its stated scope

The approval record describes VISTAKON (senofilcon A) Contact Lens, Clear and Visibility Tinted with UV Blocker, and the summary of safety and effectiveness data names the device generic as a senofilcon A hydrophilic contact lens. The approval statement covers spherical and multifocal lens forms for optical correction of refractive ametropia in phakic or aphakic persons with non-diseased eyes, and it addresses daily wear and extended wear schedules. [4][9]

The filing lists the applicant at 7500 Centurion Parkway, Suite 100, Jacksonville, FL 32256, and records the advisory committee as ophthalmic with no panel recommendation noted in the summary document. That address is a filing address in the FDA record, not a verified corporate headquarters. [9][4]

2026 supplement activity on P040045

Three 30-Day Notice supplements were decided in late 2026, each coded OK30 and each tied to process changes for manufacturer, sterilizer, packager or supplier. S145, received August 7, 2026 and decided September 2, 2026, covers qualification of an existing manufacturing line to produce VISTAKON (senofilcon A) contact lenses at the Jacksonville, Florida facility. [3]

S146, received September 18, 2026 and decided October 8, 2026, covers qualification of an alternate heat-sealing system in an existing manufacturing line at the Limerick, Ireland facility. S147, received September 30, 2026 and decided October 16, 2026, covers addition of an alternate raw material supplier for the color additive used in manufacturing, at facilities in Jacksonville, Florida and Limerick, Ireland. [2][1]

How to read the filing collection

The supplied collection holds four linked PMA records: three OK30 decisions and one APPR decision. The smaller record sample of four rows carries the same split of three OK30 and one APPR. These counts describe the supplied filings as of the snapshot date and are not measures of total company portfolio, sales or safety performance. [1][2][3][4]

The supplements are administrative manufacturing notices rather than new device approvals, and the record does not disclose outcomes, inspection results beyond the 2005 date, or commercial status. No recall records appear in the supplied sample. [1][2][3][9]

Applicant identity versus brand

The FDA records identify the legal applicant as Vistakon, Division of Johnson & Johnson Vision Car, and the summary document gives the applicant address as VISTAKON, Division of Johnson & Johnson Vision Care. The relationship implied by the division wording is stated in the filings; no separate corporate ownership, website or customer information is documented in the public documents. [9][1]